BRPI0612431A2 - composiÇÕes e mÉtodos para o tratamento da infecÇço hiv com cupredoxina e citocromo c - Google Patents
composiÇÕes e mÉtodos para o tratamento da infecÇço hiv com cupredoxina e citocromo cInfo
- Publication number
- BRPI0612431A2 BRPI0612431A2 BRPI0612431-3A BRPI0612431A BRPI0612431A2 BR PI0612431 A2 BRPI0612431 A2 BR PI0612431A2 BR PI0612431 A BRPI0612431 A BR PI0612431A BR PI0612431 A2 BRPI0612431 A2 BR PI0612431A2
- Authority
- BR
- Brazil
- Prior art keywords
- cupredoxin
- cytochrome
- methods
- compositions
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/80—Cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68283305P | 2005-05-20 | 2005-05-20 | |
US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
US78086806P | 2006-03-10 | 2006-03-10 | |
PCT/US2006/019565 WO2006127514A2 (fr) | 2005-05-20 | 2006-05-19 | Compositions et methodes pour traiter une infection vih a l'aide de cupredoxine et de cytochrome c |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0612431A2 true BRPI0612431A2 (pt) | 2009-02-10 |
Family
ID=37452656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0612431-3A BRPI0612431A2 (pt) | 2005-05-20 | 2006-05-19 | composiÇÕes e mÉtodos para o tratamento da infecÇço hiv com cupredoxina e citocromo c |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1883650A4 (fr) |
JP (1) | JP2008545398A (fr) |
KR (1) | KR20080024124A (fr) |
AU (1) | AU2006251644A1 (fr) |
BR (1) | BRPI0612431A2 (fr) |
CA (1) | CA2608398A1 (fr) |
IL (1) | IL187160A0 (fr) |
MX (1) | MX2007014599A (fr) |
NO (1) | NO20076389L (fr) |
WO (1) | WO2006127514A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491394B2 (en) | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
AU2006284490A1 (en) * | 2005-07-19 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to control angiogenesis with cupredoxins |
WO2007012004A2 (fr) | 2005-07-19 | 2007-01-25 | The Board Of Trustees Of The University Of Illinois | Agents de transport utiles pour traverser la barriere hemato-encephalique et pour penetrer dans les cellules cancereuses du cerveau, methodes d'utilisation de ces derniers |
BRPI0718360A2 (pt) * | 2006-12-04 | 2013-11-12 | Univ Illinois | "composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg" |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2436224A1 (fr) * | 2001-02-15 | 2002-10-03 | The Board Of Trustees Of The University Of Illinois | Facteurs cytotoxiques destines a moduler la mort cellulaire |
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
WO2006127477A2 (fr) * | 2005-05-20 | 2006-11-30 | The Board Of Trustees Of The University Of Illinois | Compositions et methodes de traitement du paludisme au moyen de cupredoxines et de cytochromes |
-
2006
- 2006-05-19 JP JP2008512556A patent/JP2008545398A/ja active Pending
- 2006-05-19 KR KR1020077028986A patent/KR20080024124A/ko not_active Application Discontinuation
- 2006-05-19 BR BRPI0612431-3A patent/BRPI0612431A2/pt not_active IP Right Cessation
- 2006-05-19 CA CA002608398A patent/CA2608398A1/fr not_active Abandoned
- 2006-05-19 WO PCT/US2006/019565 patent/WO2006127514A2/fr active Application Filing
- 2006-05-19 EP EP06770729A patent/EP1883650A4/fr not_active Withdrawn
- 2006-05-19 MX MX2007014599A patent/MX2007014599A/es unknown
- 2006-05-19 AU AU2006251644A patent/AU2006251644A1/en not_active Abandoned
-
2007
- 2007-11-05 IL IL187160A patent/IL187160A0/en unknown
- 2007-12-11 NO NO20076389A patent/NO20076389L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20076389L (no) | 2008-02-20 |
AU2006251644A1 (en) | 2006-11-30 |
WO2006127514A3 (fr) | 2008-06-26 |
JP2008545398A (ja) | 2008-12-18 |
WO2006127514A2 (fr) | 2006-11-30 |
KR20080024124A (ko) | 2008-03-17 |
IL187160A0 (en) | 2008-02-09 |
CA2608398A1 (fr) | 2006-11-30 |
EP1883650A2 (fr) | 2008-02-06 |
MX2007014599A (es) | 2008-02-07 |
EP1883650A4 (fr) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013032974A2 (pt) | "derivados de 1,6-diazabiciclo [3,2,1]-octan-7-ona, seus usos, e composições farmacêuticas". | |
BR112015014714A2 (pt) | compostos carbamoilpiridona policíclicos e seu uso farmacêutico | |
BR112013028813A2 (pt) | derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas | |
BR112015003592A2 (pt) | derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas | |
BRPI0810064B8 (pt) | compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos | |
BR112014010590A2 (pt) | 18-metil-6,7-metilen-3-oxo-17-pregn-4-eno-21,17?-carbolactonas, preparações farmacêuticas contendo os compostos mencionados e seu uso na terapia da endometriose | |
BRPI0813237B8 (pt) | composto, método para preparar o composto, medicamento, e, uso do composto | |
BR112015000615A2 (pt) | purinas macrocíclicas para o tratamento de infecções virais | |
BRPI0516751A (pt) | pirimidinas bicìclicas que inibem hcv | |
BR112014000938A2 (pt) | quinazolinas substituídas, a preparação das mesmas e o uso das mesmas em composições farmacêuticas | |
BRPI0519674A2 (pt) | sulfonil pirrolidinas, mÉtodo para produzir as mesmas e seu uso como drogas | |
BRPI0513196A (pt) | formulações tópicas antivirais | |
BRPI0718813B8 (pt) | compostos derivados de 1,1-dióxido de 1,4-benzotiepina, medicamento que os compreendem e seus usos | |
NO20091258L (no) | Entantiomerisk rene fosfoindoler as HIV inhibitorer | |
BR112015011036A2 (pt) | derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais | |
BR0315937A (pt) | Composto, composição para a profilaxia ou tratamento de infecções virais, e, método para a profilaxia ou tratamento de infecções da hepatite c e doenças associadas com tais infecções em um hospedeiro vivo | |
BR112015003778A2 (pt) | profármaco tenofovir e usos farmacêuticos do mesmo | |
BR112014011055A2 (pt) | novos derivados de [1,2,3]triazolo[4,5-d]pirimidina | |
BRPI0611863A2 (pt) | composto, bem como composiÇço e kit compreendendo o mesmo, composto intermediÁrio na preparaÇço do mesmo, mÉtodo para tratamento e uso do mesmo | |
BRPI0720569B8 (pt) | compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária | |
EA201791850A1 (ru) | Борсодержащие малые молекулы | |
BRPI0815547B8 (pt) | composição farmacêutica compreendendo depsipeptídeos cíclicos, e seus usos | |
BR112015014458A2 (pt) | derivados de manose para o tratamento de infecções bacterianas | |
BR112014012983A2 (pt) | derivados de pirrol | |
BR112015018547A2 (pt) | microbiocidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |